Inhibition and modification of benzo(a)pyrene induced chemical carcinogenesis by ascorbic acid alone or in combination with α-tocopherol in wistar rats

Experimental Oncology

Volumn 24, Issue 4, 2002, Pages 274-278

  Karkabounas, S ^a   Binolis, J ^a   Zelovitis, J ^a   Kotsis, N ^a   Charalabopoulos, A ^a   Avdikos, A ^a   Zuridakis, A ^a   Liasko, R ^a   Giannakopoulos, X ^a   Charalabopoulos, K ^a  

^a NONE

Author keywords

Ascorbic acid; Benzo(a)pyrene; Chemical carcinogenesis; Polycyclic hydrocarbons; Tocopherol; Wistar rats

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; BENZO[A]PYRENE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; CANCER PREVENTION; CHEMICAL CARCINOGENESIS; CONTROLLED STUDY; DRUG POTENCY; MALE; NONHUMAN; RAT;

EID: 0036971595     PISSN: 02043564     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Allison AC, Nash T. Electron donation and acceptance by carcinogenic compounds. Nature 1963; 197: 758-63.
2. Kallistratos G, Fasske E, Karkabounas S, Charalabopoulos K. Prolongation of the survival time of tumor bearing Wistar rats through a simultaneous oral administration of vitamins C & E and selenium with glutathione. Progr Clin Biol Res 1989; 259: 377-89.
3. Kallistratos G, Evangelou A, Agnantis N, Fasske E, Karkabounas S, Donos A. Enhancement of the antineoplastic effect of anticarcinogens on benzo(a)pyrene treated rats, in relation to their number and biological activity. Cancer Lett 1994; 82: 153-65.
4. Shklar G, Oh SK. Experimental basis for cancer prevention by vitamin E. Cancer Invest 2000; 18: 214-22.
5. Kaiser HE, Krenn M, Boobey BJr, Bodey B. Growth inhibitors in the treatment of malignant neoplasms. In Vivo 2000; 14: 287-96.
6. Halliwell B. The antioxidant paradox. Lancet 2000; 355: 1179-80.
7. Mobio TA, Baudrimont I, Sanni A, Shier TW, Saboureau D, Dano SD, Veno Y, Steyn PS, Creppy EE. Prevention by vitamin E of DNA fragmentation and apoptosis induced by fumonisin B1 in C6 glioma cells. Arch Toxicol 2000; 74: 112-9.
8. Cascinu S, Ligi M, Del Ferro E, Foglietti G, Cioccolini P, Staccioli MP, Carnevali A, Luigi Rossi MB, Alessandroni P, Giordani P, Catalano V, Polizzi V, Agostinelli R, Muretto P, Catalano G. Effects of calcium and vitamin supplementation on colon cell proliferation in colorectal cancer. Cancer Invest 2000; 18: 411-6.
9. Charalabopoulos K, Karkabounas S, Ioachim E, Papalimneou V, Syrigos K, Evangelou A, Agnantis N, Hadjiiliadis N. Antitumor and toxic effects on Wistar rats of two new platinum complexes. Eur J Clin Invest 2002; 32: 129-33.
10. Geacintov N. Mechanisms of reaction of polycyclic aromatic epoxide derivatives with nucleic acids. In: Polycyclic aromatic hydrocarbon carcinogenesis: structure-activity relationships. Yang SK, Silverman BD, eds. CRC Press, 1988; Vol II, 181-206.
11. Josephy PD. The role of peroxidase-catalyzed activation of aromatic amines in breast cancer. Mutagenesis 1996; 11: 3-12.
12. Francheschi S. Nutrients and food groups and large bowel cancer in Europe. Eur J Cancer Prev 1999; (Suppl): 49-52.
13. Sakagami H, Fujiwara E, Yokote Y, Akaheine K, Asako K, Kochi M, Hara E, Shirahata A. Changes in intracellular concentrations of amino acids and polyamines during the apoptosis of HL-60 cells. Anticancer Res 2000; 20: 265-70.
14. Cividalli A, Mauro F, Livdi E, Ceciarelli F, Altarista P, Cruciani G, Tirindelli M, Danessi D. Schedule dependent toxicity and efficacy of combined gliucitabine/paclitaxel treatment in mouse adenocarcinoma. J Cancer Res Clin Oncol 2000; 126: 461-7.
15. Jacob RA. The role of micronutrients in DNA synthesis and maintenance. Adv Exp Med Biol 1999; 472: 101-3.
16. Arcos JC, Argus MF. Molecular geometry and carcinogenic activity of aromatic compounds. Adv Cancer Res 1968; 11: 305-14.
17. Wu K, Helzlsouer KJ, Alberg AJ, Comstock GW, Norkus EP, Hoffman SC. A prospective study of plasma ascorbic acid concentrations and breast cancer. Cancer Causes Control 2000; 11: 279-83.
18. Schlegel JU, Pipkin GE, Nishimura R, Shultz GN. The role of ascorbic acid in the prevention of bladder tumor formation. J Urol 1970; 103: 115-23.
19. Price JM, Wear JB, Brown RR, Satter EJ, Olson C. Studies on etiology of carcinoma of the urinary bladder. J Urol 1960; 83: 376-84.
20. Cameron E, Pauling L. Ascorbic acid and the glycosaminoglycans. An orthomolecular approach to cancer and other diseases. Oncology 1973; 27: 181-93.
21. Ronco A, De Stefani E, Baffetta P, Deneo-Pellegrini H, Mendilaharsu M, Leborgne F. Vegetables, fruits, and related nutrients and risk of breast cancer: a case study in Vanguay. Nutr Cancer 1999; 35: 11-9.
22. Gandini S, Merzewich H, Robertson C, Boyle P. Meta-analysis of studies on breast cancer and diet: the role of fruit and vegetable consumption and the intake of associated micronutrients. Eur J Cancer 2000; 36: 636-46.
23. Charalabopoulos K, Karkabounas S, Papalimneou V, Vezyraki P, Kalfakakou V, Evangelou A. Chemical carcinogens and inactivating substances. Eur Ass Cancer Res, EACR XVI 2000; Abstr. GP12, p.100, Salonica Gr.
24. Jaffe WG. The influence of wheat germ oil on the production of tumors in rats by ethylchloranthrene. Exp Med Surg 1946; 4: 278-87.
25. Shapiro JR. Selenium and carcinogenesis. Ann NY Acad Sci 1972; 192: 215-23.